This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Rhabdomyolysis and fluvoxamine

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Rhabdomyolysis and fluvoxamine

Myalgia is a rare side effect of fluvoxamine (1).

A case report (1) describes rhabdomyolysis due to fluvoxamine monotherapy for obsessive-compulsive disorder

  • a young adolescent developed pain in the extremities, and an increase in serum creatine kinase (CK) and myoglobin during fluvoxamine treatment
  • adverse reactions were reversed immediately after the medicine was changed to another SSRI - sertraline

Reference:

  • Zhang F, Gong W, Cui Z, et al. Rhabdomyolysis in a male adolescent associated with monotherapy of fluvoxamine. European Journal of Hospital Pharmacy Published Online First: 02 December 2022. doi: 10.1136/ejhpharm-2022-00353

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page